-=Recro Pharma (REPH) reported earnings on Mon 11 May 20 (b/o)

Recro Pharma (NASDAQ:REPH): Q1 GAAP EPS of -$0.33 misses by $0.30.

Revenue of $21.78M (-13.1% Y/Y) beats by $2.33M.

Net loss: ($7.7M); loss/share: ($0.33).

Non-GAAP EBITDA: $2.7M.

2020 guidance: Revenue: $80M - 85M from $97M - 100M; non-GAAP EBITDA: $26M - 30M (standalone).

Recro Pharma Inc is a contract development and manufacturing company. The company is engaged in the development, formulation, regulatory support, manufacturing, and packaging of oral solid dose drug products. Its product portfolio includes Ritalin LA; Focalin XR; Verelan PM, SR and Verapamil PM; Verapamil SR and Zohydro ER.

Earnings this week : May 11 - 15, 20 (wk 20)

Monday (May 11)

• Morning: AMRX AN AVYA CAH CEVA CHH CLF CEIX CLR COTY EBIX ETR GOGO GBDC ICPT XENT MGLN MAR MYL ON ORA PK RDNT TERP UAA UNVR XHR ZBH
• Afternoon: TXG XLRN AIMT AMBC AMCR AEE AFG AMN BE BHF CABO CBT CZR CDLX CSOD DDOG DRH DIOD ERI ECPG ET ENSG ETH EB EXTR FATE FOE FBM G GDOT GSKY GO GWPH HALO HHC IIVI IPAR IFF JCOM KAMN LTHM LOGI MBI MESA MIME NHI NSA PLYA PTLA KWR REPH RETA RPAY SGMO SCSC SPG SUN TME TLRY

Tuesday (May 12)

• Morning: BNTX CVLT DUK DT FI HMC IR MAC NOVT FLOW TUFN VSH
• Afternoon: EGHT ADPT ALC ALGT NVST HCAT INFN OR PGNY RXN RLJ SWAV VREX 

Wednesday (May 13)

• Morning: CYBR PGTI TSEM
• Afternoon: ONEM CSCO FLO JACK NVGS OII SDC STE VRTU

Thursday (May 14)

• Morning: AZUL BAM AG GDS KEM NICE NCLH NVMI SPNS SSYS WNC WIX
• Afternoon: ACB AMAT CVET DENN FTCH GLOB GTBIF HBM NEWR NLOK SSRM

Friday (May 15) 

• Morning: JD PBF VFC